PUSCEDDU, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 39.228
NA - Nord America 1.910
AS - Asia 1.513
SA - Sud America 240
AF - Africa 48
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 42.943
Nazione #
IT - Italia 35.482
NL - Olanda 3.189
US - Stati Uniti d'America 1.856
SG - Singapore 654
CN - Cina 437
BR - Brasile 181
VN - Vietnam 170
SE - Svezia 124
FR - Francia 96
DE - Germania 80
GB - Regno Unito 67
FI - Finlandia 56
HK - Hong Kong 54
IN - India 47
UA - Ucraina 31
CA - Canada 28
KR - Corea 22
MX - Messico 22
ES - Italia 20
PL - Polonia 19
ZA - Sudafrica 17
BD - Bangladesh 16
IQ - Iraq 16
EC - Ecuador 14
AR - Argentina 13
AT - Austria 12
CO - Colombia 11
ID - Indonesia 11
TR - Turchia 10
BE - Belgio 9
IR - Iran 9
PK - Pakistan 8
VE - Venezuela 8
IE - Irlanda 7
JP - Giappone 7
RU - Federazione Russa 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
MA - Marocco 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
KG - Kirghizistan 5
TN - Tunisia 5
GR - Grecia 4
IL - Israele 4
LT - Lituania 4
MK - Macedonia 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
TH - Thailandia 4
AU - Australia 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
MY - Malesia 3
NP - Nepal 3
RS - Serbia 3
BO - Bolivia 2
EG - Egitto 2
GA - Gabon 2
HU - Ungheria 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
SC - Seychelles 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 42.943
Città #
Cagliari 34.343
Amsterdam 3.181
Uta 911
Singapore 389
Dallas 271
Ashburn 258
San Jose 156
Boardman 97
Beijing 82
Nyköping 70
Fairfield 69
Chandler 65
Los Angeles 63
Hong Kong 48
The Dalles 48
Ho Chi Minh City 47
Helsinki 46
New York 46
Santa Clara 43
Houston 39
Wilmington 37
Woodbridge 36
Council Bluffs 35
Hanoi 35
Hefei 34
Seattle 32
Dearborn 31
Shanghai 26
Lauterbourg 23
Nanjing 22
Orem 22
Seoul 22
Guangzhou 20
Boston 19
Cambridge 19
Rome 19
Buffalo 17
Munich 17
São Paulo 17
Dong Ket 16
Jacksonville 16
Milan 16
Redondo Beach 16
Chicago 15
Frankfurt am Main 15
Ann Arbor 14
Chennai 14
Nuremberg 14
London 13
Montreal 13
Shenzhen 13
Düsseldorf 12
Poplar 10
San Diego 10
Johannesburg 9
Pune 9
Stockholm 9
Warsaw 9
Zhengzhou 9
Brooklyn 8
Haiphong 8
Atlanta 7
Dublin 7
Hangzhou 7
Lappeenranta 7
Biên Hòa 6
Guayaquil 6
Jiaxing 6
Leawood 6
Selargius 6
Tashkent 6
Toronto 6
Baghdad 5
Bishkek 5
Brussels 5
Mexico City 5
Nairobi 5
Nanchang 5
New Delhi 5
Olbia 5
Quito 5
Shenyang 5
Turin 5
Bari 4
Belo Horizonte 4
Bexley 4
Denver 4
Dubai 4
Jinan 4
La Maddalena 4
Lima 4
Manchester 4
Menlo Park 4
Ninh Bình 4
Paris 4
Portsmouth 4
Redmond 4
Rio de Janeiro 4
Riyadh 4
Romainville 4
Totale 41.216
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 3.240
Molecular-biology-driven treatment for metastatic colorectal cancer 2.771
The Osteological Collection of the University of Cagliari: From Early Neolithic to Modern Age 2.654
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.636
Le collezioni scheletriche umane di epoca Nuragica dell'Università di Cagliari: sintesi delle conoscenze e nuovi dati paleobiologici 2.525
Sepolture tardo puniche dal lotto 7 di Tuvixeddu: due storie di bambini mai nati e alcune osservazioni epigrafiche. 2.486
Le collezioni scheletriche umane di epoca nuragica dell’Università di Cagliari: sintesi delle conoscenze e nuovi dati paleobiologici 2.429
Necropoli di Cannas di Sotto, Carbonia. Lo scavo della tomba 12. Notizia preliminare 2.322
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.124
Primi dati paleobiologici sugli individui rinvenuti all’interno della Tomba 3 del sito di Cap de Forma (Minorca) 2.017
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy 1.909
Immunotherapy and Cancer: The Multi-Omics Perspective 1.609
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.357
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.222
The burials of San Giuliano church (Selargius, Sardinia): preliminary data 1.181
The paleopathological collection of Cagliari University: case studies and future proposal 1.178
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 987
null 918
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 786
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 741
Uncovering key targets of success for immunotherapy in pancreatic cancer 720
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 596
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 586
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 435
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial 384
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 334
CD44: A New Prognostic Marker in Colorectal Cancer? 271
A new prognostic score for biliary tract cancer: a multicenter experience 218
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 217
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 210
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 199
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 192
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 183
Medical management of malignant bowel obstruction: our center experience 173
Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions 170
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 170
Image analysis techniques applied on a sample of auditory ossicles from Sardinia 123
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 117
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 106
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 103
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 102
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 100
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 100
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 94
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 93
Totale 43.088
Categoria #
all - tutte 54.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.249 0 0 0 0 0 0 0 0 0 533 474 242
2021/20222.178 201 183 103 182 157 138 104 101 191 264 292 262
2022/20233.065 345 550 482 190 225 192 144 266 177 159 213 122
2023/20242.976 121 91 97 141 251 510 469 201 159 228 358 350
2024/202515.257 3.279 5.070 916 808 433 608 442 61 113 3.263 84 180
2025/20263.548 278 248 430 342 278 289 729 385 236 333 0 0
Totale 43.088